BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25993060)

  • 1. shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.
    Wang H; Sun R; Gu M; Li S; Zhang B; Chi Z; Hao L
    PLoS One; 2015; 10(5):e0127224. PubMed ID: 25993060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
    Wang H; Sun R; Chi Z; Li S; Hao L
    Mol Cell Biochem; 2017 Sep; 433(1-2):1-12. PubMed ID: 28382490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers.
    Harada M; Kotake Y; Ohhata T; Kitagawa K; Niida H; Matsuura S; Funai K; Sugimura H; Suda T; Kitagawa M
    Genes Cells; 2014 Jun; 19(6):504-16. PubMed ID: 24774443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma.
    Fujiwara-Okada Y; Matsumoto Y; Fukushi J; Setsu N; Matsuura S; Kamura S; Fujiwara T; Iida K; Hatano M; Nabeshima A; Yamada H; Ono M; Oda Y; Iwamoto Y
    Br J Cancer; 2013 Mar; 108(4):836-47. PubMed ID: 23462806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
    Tu Y; Cheng S; Zhang S; Sun H; Xu Z
    Int J Mol Med; 2013 Jan; 31(1):113-9. PubMed ID: 23129065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling.
    Wang C; Zhao N; Sato F; Tanimoto K; Okada H; Liu Y; Bhawal UK
    Bioengineered; 2021 Dec; 12(2):9128-9139. PubMed ID: 34696665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 10. Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.
    Li W; Cao J; Liu J; Chu W; Zhang C; Chen S; Kang Z
    Cell Mol Biol Lett; 2019; 24():19. PubMed ID: 30891073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
    Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo.
    Zhao J; Wei XL; Jia YS; Zheng JQ
    Eur J Pharmacol; 2008 Jan; 579(1-3):50-7. PubMed ID: 17976575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exogenous antizyme 1 gene transfection inhibits proliferation and promotes apoptosis of human neuroblastoma SH-SY5Y cells in vitro].
    Jiang L; Ma WL; Li J; Peng YF; Xu B; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1709-13. PubMed ID: 18024296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression.
    Du X; Wang H; Xu F; Huang Y; Liu Z; Liu T
    Mol Med Rep; 2015 Jul; 12(1):953-9. PubMed ID: 25779425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of YB-1 protein on the biological behaviour in K562/A02 cells].
    Shen HL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):342-7. PubMed ID: 21518485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of α3 neuronal nicotinic acetylcholine receptor on cell apoptosis and p38 MAPK signal transduction pathway in SH-SY5Y cells].
    Zhang XL; Qi XL; Ren JM; Wu CX; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):116-20. PubMed ID: 23710919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
    Song J; Hou L; Ju C; Zhang J; Ge Y; Yue W
    Eur J Pharmacol; 2013 Feb; 702(1-3):235-41. PubMed ID: 23376416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
    To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
    Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.